← Back to headlines
Summit Therapeutics Files for $500 Million Common Stock Offering
Summit Therapeutics has filed for a $500 million common stock offering, leading to a more than 9% slide in its shares.
9 Jun, 21:14 — 9 Jun, 21:14
Sources
Showing 1 of 1 sources
Related Stories
Lululemon Faces Deepening Sales Decline and Lowers Annual Revenue Forecast Again
13m ago
Volkswagen Approves Major Restructuring Plan With 50,000 Job Cuts
23m ago
Air Canada Expands Network With New Transatlantic and European Routes
24m ago
Crusoe Secures $13 Billion AI Cloud Computing Deal With Jane Street
1h ago